Gary E. Mason
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Genetics 7
- Glioma Diagnosis and Treatment 7
-
- Prostate Cancer Treatment and Research 8
- Co-authors
- Laura Liberman (1 shared paper)D. David Dershaw (1 shared paper)Elizabeth Ann Morris (1 shared paper)Ian F. Pollack (4 shared papers)Ashok Panigrahy (4 shared papers)Regina I. Jakacki (3 shared papers)Hideho Okada (3 shared papers)Theresa L. Whiteside (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (3 papers)Acta Neuropathologica (2 papers)Cancer Discovery (2 papers)Prostate Cancer and Prostatic Diseases (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Gary E. Mason
29 papers receiving 2.6k citations
Gary E. Mason's Hit Papers
Peers
Comparison fields: 5 of 83
- Genetics 689
- Cancer Research 603
- Oncology 953
- Pathology and Forensic Medicine 494
- Pulmonary and Respiratory Medicine 685
Countries citing papers authored by Gary E. Mason
This map shows the geographic impact of Gary E. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Mason more than expected).
Fields of papers citing papers by Gary E. Mason
This network shows the impact of papers produced by Gary E. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Mason. The network helps show where Gary E. Mason may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary E. Mason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency Hit paper breakdown → | 2016 | 707 |
| 2 | Comprehensive Analysis of Hypermutation in Human Cancer Hit paper breakdown → | 2017 | 605 |
| 3 | Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2023 | 240 |
| 4 | 2006 | 158 | |
| 5 | Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial Hit paper breakdown → | 2023 | 131 |
| 6 | 2022 | 103 | |
| 7 | 2019 | 82 | |
| 8 | 2016 | 77 | |
| 9 | 2021 | 73 | |
| 10 | 2020 | 67 | |
| 11 | 2013 | 59 | |
| 12 | 2016 | 58 | |
| 13 | 2015 | 50 | |
| 14 | 2016 | 46 | |
| 15 | 2020 | 36 | |
| 16 | 2021 | 32 | |
| 17 | 2021 | 30 | |
| 18 | 2019 | 29 | |
| 19 | 2020 | 24 | |
| 20 | 2015 | 23 |
About Gary E. Mason
Gary E. Mason is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 30 papers that have together received 2.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Glioma Diagnosis and Treatment (7 papers), Genetic factors in colorectal cancer (6 papers), PARP inhibition in cancer therapy (5 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Genetics (689 citations), Cancer Research (603 citations), Oncology (953 citations), Pathology and Forensic Medicine (494 citations) and Pulmonary and Respiratory Medicine (685 citations). Gary E. Mason has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Laura Liberman, D. David Dershaw, Elizabeth Ann Morris, Ian F. Pollack, Ashok Panigrahy, Regina I. Jakacki, Hideho Okada, Theresa L. Whiteside, Lisa Helene Butterfield and Daniel Paul Normolle. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Acta Neuropathologica, Cancer Discovery and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.